Sanofi Listed on the DJSI Sustainability World Index

Numbers can be impressive, but they don’t always tell the whole story. For example, it’s the sixth consecutive year Sanofi has been named to the 2012/2013 Dow Jones Sustainability World Index (DJSI), the first and most prestigious assessment of corporate social responsibility.  The deeper story includes the value of our CSR programs – and the people behind them – that contribute to our society.

“Being listed on the index is based on a yearly assessment and is never guaranteed,” said John Spinnato, Vice President, North America Corporate Social Responsibility. “This is yet another accomplishment in Sanofi’s CSR journey. Our employees should take pride in knowing that their CSR practices contributed to this recognition and are designed to make a positive different to people and our planet.”

Although a detailed assessment of Sanofi’s scores is under way, we already know that:

• Sanofi was one of only seven pharmaceutical companies on the index out of 60 applicants from our industry. In total, DJSI World evaluates 2,500 companies from 57 different industry sectors.
• We improved our scores on 14 of 22 corporate social responsibility topics.
• A global, cross-functional network business colleagues assisted the Sanofi CSR Excellence team in completing a detailed 100-question survey. This team provided responses to more than 100 questions from areas including strategy, finance, customer, product, governance, stakeholder engagement, supply chain, environment and human resources. 

"Although we are included in the DJSI for 2012/2013," says John Spinnato, "Sanofi’s CSR colleagues strive for continuous improvement of our scores every year to remain a leader in the field." 

For more information about Sanofi’s Global CSR efforts click on www.csrreporting.sanofi.com, and to learn about Sanofi’s North American CSR Best practices click on www.sanofi.us at Our Responsibility.

About Sanofi
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms; diabetes solutions, human vaccine, innovation drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US, also referred to as sanofi-aventis U.S. LLC. For more information on Sanofi US, please visit http://www.sanofi.us or call 1-800-981-2491.